Cargando…

Mortality in children, adolescents and adults with sickle cell anemia in Rio de Janeiro, Brazil

OBJECTIVE: To determine the mortality rate of children, adolescents and adults with sickle cell anemia in Rio de Janeiro, Brazil. METHODS: The number of deaths, the mortality rate and the causes of deaths in patients with sickle cell anemia who were treated and followed up at our institution for 15...

Descripción completa

Detalles Bibliográficos
Autores principales: Lobo, Clarisse Lopes de Castro, Nascimento, Emilia Matos do, Jesus, Leonardo José Carvalho de, Freitas, Thiago Gotelip de, Lugon, Jocemir Ronaldo, Ballas, Samir K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002966/
https://www.ncbi.nlm.nih.gov/pubmed/29519371
http://dx.doi.org/10.1016/j.bjhh.2017.09.006
_version_ 1783332279107452928
author Lobo, Clarisse Lopes de Castro
Nascimento, Emilia Matos do
Jesus, Leonardo José Carvalho de
Freitas, Thiago Gotelip de
Lugon, Jocemir Ronaldo
Ballas, Samir K.
author_facet Lobo, Clarisse Lopes de Castro
Nascimento, Emilia Matos do
Jesus, Leonardo José Carvalho de
Freitas, Thiago Gotelip de
Lugon, Jocemir Ronaldo
Ballas, Samir K.
author_sort Lobo, Clarisse Lopes de Castro
collection PubMed
description OBJECTIVE: To determine the mortality rate of children, adolescents and adults with sickle cell anemia in Rio de Janeiro, Brazil. METHODS: The number of deaths, the mortality rate and the causes of deaths in patients with sickle cell anemia who were treated and followed up at our institution for 15 years were determined and compared to data available for the Brazilian population. RESULTS: The overall number of deaths was 281 patients with a mortality rate of 16.77%. Survival probability was significantly higher in females. The number of deaths and the mortality rate were age-specific with a significant increase in the 19- to 29-year-old age group. The remaining life expectancy of the patients with sickle cell anemia was less than that of Brazilians at large. The gap between the two was about 20 years for ages between one and five years with this gap decreasing to ten years after the age of 65 years. The most common causes of death were infection, acute chest syndrome, overt stroke, organ damage and sudden death during painful crises. CONCLUSION: To the best of our knowledge, this is the first Brazilian study in a single institution in Rio de Janeiro; the mortality rate was 18.87% among adult patients with sickle cell anemia. The mortality rates in children and adults are higher than those reported in developed countries of the northern hemisphere.
format Online
Article
Text
id pubmed-6002966
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Sociedade Brasileira de Hematologia e Hemoterapia
record_format MEDLINE/PubMed
spelling pubmed-60029662018-06-15 Mortality in children, adolescents and adults with sickle cell anemia in Rio de Janeiro, Brazil Lobo, Clarisse Lopes de Castro Nascimento, Emilia Matos do Jesus, Leonardo José Carvalho de Freitas, Thiago Gotelip de Lugon, Jocemir Ronaldo Ballas, Samir K. Hematol Transfus Cell Ther Original Article OBJECTIVE: To determine the mortality rate of children, adolescents and adults with sickle cell anemia in Rio de Janeiro, Brazil. METHODS: The number of deaths, the mortality rate and the causes of deaths in patients with sickle cell anemia who were treated and followed up at our institution for 15 years were determined and compared to data available for the Brazilian population. RESULTS: The overall number of deaths was 281 patients with a mortality rate of 16.77%. Survival probability was significantly higher in females. The number of deaths and the mortality rate were age-specific with a significant increase in the 19- to 29-year-old age group. The remaining life expectancy of the patients with sickle cell anemia was less than that of Brazilians at large. The gap between the two was about 20 years for ages between one and five years with this gap decreasing to ten years after the age of 65 years. The most common causes of death were infection, acute chest syndrome, overt stroke, organ damage and sudden death during painful crises. CONCLUSION: To the best of our knowledge, this is the first Brazilian study in a single institution in Rio de Janeiro; the mortality rate was 18.87% among adult patients with sickle cell anemia. The mortality rates in children and adults are higher than those reported in developed countries of the northern hemisphere. Sociedade Brasileira de Hematologia e Hemoterapia 2018 2017-12-06 /pmc/articles/PMC6002966/ /pubmed/29519371 http://dx.doi.org/10.1016/j.bjhh.2017.09.006 Text en © 2017 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Lobo, Clarisse Lopes de Castro
Nascimento, Emilia Matos do
Jesus, Leonardo José Carvalho de
Freitas, Thiago Gotelip de
Lugon, Jocemir Ronaldo
Ballas, Samir K.
Mortality in children, adolescents and adults with sickle cell anemia in Rio de Janeiro, Brazil
title Mortality in children, adolescents and adults with sickle cell anemia in Rio de Janeiro, Brazil
title_full Mortality in children, adolescents and adults with sickle cell anemia in Rio de Janeiro, Brazil
title_fullStr Mortality in children, adolescents and adults with sickle cell anemia in Rio de Janeiro, Brazil
title_full_unstemmed Mortality in children, adolescents and adults with sickle cell anemia in Rio de Janeiro, Brazil
title_short Mortality in children, adolescents and adults with sickle cell anemia in Rio de Janeiro, Brazil
title_sort mortality in children, adolescents and adults with sickle cell anemia in rio de janeiro, brazil
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002966/
https://www.ncbi.nlm.nih.gov/pubmed/29519371
http://dx.doi.org/10.1016/j.bjhh.2017.09.006
work_keys_str_mv AT loboclarisselopesdecastro mortalityinchildrenadolescentsandadultswithsicklecellanemiainriodejaneirobrazil
AT nascimentoemiliamatosdo mortalityinchildrenadolescentsandadultswithsicklecellanemiainriodejaneirobrazil
AT jesusleonardojosecarvalhode mortalityinchildrenadolescentsandadultswithsicklecellanemiainriodejaneirobrazil
AT freitasthiagogotelipde mortalityinchildrenadolescentsandadultswithsicklecellanemiainriodejaneirobrazil
AT lugonjocemirronaldo mortalityinchildrenadolescentsandadultswithsicklecellanemiainriodejaneirobrazil
AT ballassamirk mortalityinchildrenadolescentsandadultswithsicklecellanemiainriodejaneirobrazil